Request Demo
Last update 29 Aug 2025
Phaeno Therapeutics (Hangzhou) Co., Ltd.
Last update 29 Aug 2025
Overview
Tags
Infectious Diseases
Skin and Musculoskeletal Diseases
Urogenital Diseases
Small molecule drug
Chemical drugs
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20252614
复发性生殖器疱疹参与者中初步评估HN0037片的有效性和安全性：一项IIa期、随机、双盲、平行入组、安慰剂对照、剂量探索的多中心临床试验
[Translation] Preliminary evaluation of the efficacy and safety of HN0037 tablets in participants with recurrent genital herpes: a phase IIa, randomized, double-blind, parallel-group, placebo-controlled, dose-finding, multicenter clinical trial
CTR20210378
HN0037 片在健康成年受试者中单次和多次给药的安全性、耐受性和药代动力学特征的Ⅰ期临床研究
[Translation] Phase I clinical study on the safety, tolerability and pharmacokinetic characteristics of HN0037 tablets after single and multiple administration in healthy adult subjects
CTR20201664
HN0141片在健康成年受试者中单次和多次给药的安全性、耐受性和药代动力学特征的I期临床研究
[Translation] A phase I clinical study on the safety, tolerability and pharmacokinetic characteristics of single and multiple doses of HN0141 tablets in healthy adult subjects
100 Clinical Results associated with Phaeno Therapeutics (Hangzhou) Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Phaeno Therapeutics (Hangzhou) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Phaeno Therapeutics (Hangzhou) Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 01 Sep 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Application
2
2
IND Approval
Phase 1
1
1
Phase 2
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free